Henry Schein, Inc.
Henry Schein, Inc. (0L3C.L) Stock Competitors & Peer Comparison
See (0L3C.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0L3C.L | £67.85 | -3.06% | 8.3B | 14.93 | £4.59 | N/A |
| 0R29.L | £477.94 | -1.77% | 172B | 106.84 | £4.49 | N/A |
| 0HOY.L | £104.79 | -1.63% | 156.2B | 199.16 | £0.53 | N/A |
| 0R2S.L | £373.69 | -6.93% | 142.8B | 71.06 | £5.26 | +0.88% |
| 0R2B.L | £195.43 | -2.51% | 140.1B | 22.65 | £8.64 | +0.60% |
| 0Y6X.L | £89.34 | -2.03% | 114.5B | 23.95 | £3.73 | +3.15% |
| 0JZU.L | £695.07 | -1.79% | 86.8B | 96.16 | £7.23 | +0.41% |
| 0J1R.L | £355.74 | -0.26% | 85.6B | 16.71 | £21.29 | +0.77% |
| 0HRS.L | £61.93 | -0.91% | 78B | 10.25 | £6.01 | +4.28% |
| 0HG8.L | £281.88 | -3.98% | 64.2B | 11.22 | £25.40 | +2.43% |
Stock Comparison
0L3C.L vs 0R29.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R29.L has a market cap of 172B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R29.L trades at £477.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R29.L's P/E ratio is 106.84. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R29.L's ROE of +0.16%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R29.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R29.L's competition here
0L3C.L vs 0HOY.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HOY.L has a market cap of 156.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HOY.L trades at £104.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HOY.L's P/E ratio is 199.16. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HOY.L's ROE of +0.10%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HOY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HOY.L's competition here
0L3C.L vs 0R2S.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R2S.L has a market cap of 142.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R2S.L trades at £373.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R2S.L's P/E ratio is 71.06. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R2S.L's ROE of +0.11%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R2S.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R2S.L's competition here
0L3C.L vs 0R2B.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R2B.L has a market cap of 140.1B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R2B.L trades at £195.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R2B.L's P/E ratio is 22.65. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R2B.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R2B.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R2B.L's competition here
0L3C.L vs 0Y6X.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0Y6X.L has a market cap of 114.5B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0Y6X.L trades at £89.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0Y6X.L's P/E ratio is 23.95. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0Y6X.L's ROE of +0.09%. Regarding short-term risk, 0L3C.L is less volatile compared to 0Y6X.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0Y6X.L's competition here
0L3C.L vs 0JZU.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0JZU.L has a market cap of 86.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0JZU.L trades at £695.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0JZU.L's P/E ratio is 96.16. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0JZU.L's ROE of -1.15%. Regarding short-term risk, 0L3C.L is less volatile compared to 0JZU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0JZU.L's competition here
0L3C.L vs 0J1R.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0J1R.L has a market cap of 85.6B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0J1R.L trades at £355.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0J1R.L's P/E ratio is 16.71. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0J1R.L's ROE of -2.11%. Regarding short-term risk, 0L3C.L is less volatile compared to 0J1R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0J1R.L's competition here
0L3C.L vs 0HRS.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HRS.L has a market cap of 78B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HRS.L trades at £61.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HRS.L's P/E ratio is 10.25. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HRS.L's ROE of +0.06%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HRS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HRS.L's competition here
0L3C.L vs 0HG8.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HG8.L has a market cap of 64.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HG8.L trades at £281.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HG8.L's P/E ratio is 11.22. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HG8.L's ROE of +0.13%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HG8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HG8.L's competition here
0L3C.L vs 0PMJ.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0PMJ.L has a market cap of 54.7B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0PMJ.L trades at £46.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0PMJ.L's P/E ratio is 27.95. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0PMJ.L's ROE of +0.11%. Regarding short-term risk, 0L3C.L is less volatile compared to 0PMJ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0PMJ.L's competition here
0L3C.L vs 0R19.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R19.L has a market cap of 50.7B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R19.L trades at £176.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R19.L's P/E ratio is 27.91. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R19.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R19.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R19.L's competition here
0L3C.L vs 0LO3.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0LO3.L has a market cap of 46.9B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0LO3.L trades at £281.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0LO3.L's P/E ratio is 113.03. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0LO3.L's ROE of +0.14%. Regarding short-term risk, 0L3C.L is less volatile compared to 0LO3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0LO3.L's competition here
0L3C.L vs 0J8P.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0J8P.L has a market cap of 42.9B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0J8P.L trades at £533.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0J8P.L's P/E ratio is 62.61. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0J8P.L's ROE of +0.57%. Regarding short-term risk, 0L3C.L is less volatile compared to 0J8P.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0J8P.L's competition here
0L3C.L vs 0RPS.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0RPS.L has a market cap of 41.5B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0RPS.L trades at £268.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0RPS.L's P/E ratio is 452.06. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0RPS.L's ROE of +0.06%. Regarding short-term risk, 0L3C.L is less volatile compared to 0RPS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0RPS.L's competition here
0L3C.L vs 0KW4.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0KW4.L has a market cap of 40.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0KW4.L trades at £274.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0KW4.L's P/E ratio is 51.74. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0KW4.L's ROE of +0.26%. Regarding short-term risk, 0L3C.L is less volatile compared to 0KW4.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0KW4.L's competition here
0L3C.L vs 0HTG.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HTG.L has a market cap of 37.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HTG.L trades at £154.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HTG.L's P/E ratio is -46.94. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HTG.L's ROE of -0.50%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HTG.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HTG.L's competition here
0L3C.L vs 0J6Z.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0J6Z.L has a market cap of 29.6B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0J6Z.L trades at £246.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0J6Z.L's P/E ratio is 10.45. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0J6Z.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0J6Z.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0J6Z.L's competition here
0L3C.L vs NIOX.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, NIOX.L has a market cap of 29.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while NIOX.L trades at £70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas NIOX.L's P/E ratio is 7000.00. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to NIOX.L's ROE of +0.05%. Regarding short-term risk, 0L3C.L is less volatile compared to NIOX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check NIOX.L's competition here
0L3C.L vs 0JSY.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0JSY.L has a market cap of 21.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0JSY.L trades at £261.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0JSY.L's P/E ratio is 11.98. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0JSY.L's ROE of +0.09%. Regarding short-term risk, 0L3C.L is less volatile compared to 0JSY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0JSY.L's competition here
0L3C.L vs 0KSX.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0KSX.L has a market cap of 19.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0KSX.L trades at £171.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0KSX.L's P/E ratio is 11.38. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0KSX.L's ROE of +0.14%. Regarding short-term risk, 0L3C.L and 0KSX.L have similar daily volatility (0.00).Check 0KSX.L's competition here
0L3C.L vs 0J5Q.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0J5Q.L has a market cap of 14.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0J5Q.L trades at £66.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0J5Q.L's P/E ratio is 10.94. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0J5Q.L's ROE of +0.15%. Regarding short-term risk, 0L3C.L is less volatile compared to 0J5Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0J5Q.L's competition here
0L3C.L vs 0HCK.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HCK.L has a market cap of 13.5B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HCK.L trades at £137.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HCK.L's P/E ratio is 14.48. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HCK.L's ROE of +0.11%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HCK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HCK.L's competition here
0L3C.L vs 0HVB.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HVB.L has a market cap of 12.9B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HVB.L trades at £25.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HVB.L's P/E ratio is 10.41. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HVB.L's ROE of +0.13%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HVB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HVB.L's competition here
0L3C.L vs 0NIQ.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0NIQ.L has a market cap of 12.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0NIQ.L trades at £150.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0NIQ.L's P/E ratio is 24.61. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0NIQ.L's ROE of +0.04%. Regarding short-term risk, 0L3C.L is less volatile compared to 0NIQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0NIQ.L's competition here
0L3C.L vs 0QK8.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QK8.L has a market cap of 11.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QK8.L trades at £21.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QK8.L's P/E ratio is 10.45. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QK8.L's ROE of +0.00%. Regarding short-term risk, 0L3C.L is less volatile compared to 0QK8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0QK8.L's competition here
0L3C.L vs 0I7E.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0I7E.L has a market cap of 10.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0I7E.L trades at £139.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0I7E.L's P/E ratio is 16.85. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0I7E.L's ROE of +3.94%. Regarding short-term risk, 0L3C.L is less volatile compared to 0I7E.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0I7E.L's competition here
0L3C.L vs 0LJL.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0LJL.L has a market cap of 10.5B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0LJL.L trades at £163.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0LJL.L's P/E ratio is 14.50. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0LJL.L's ROE of +0.19%. Regarding short-term risk, 0L3C.L is less volatile compared to 0LJL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0LJL.L's competition here
0L3C.L vs 0JZ2.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0JZ2.L has a market cap of 8.4B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0JZ2.L trades at £154.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0JZ2.L's P/E ratio is 39.80. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0JZ2.L's ROE of -0.41%. Regarding short-term risk, 0L3C.L and 0JZ2.L have similar daily volatility (0.00).Check 0JZ2.L's competition here
0L3C.L vs 0RKL.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0RKL.L has a market cap of 6.3B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0RKL.L trades at £199.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0RKL.L's P/E ratio is 840.86. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0RKL.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0RKL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0RKL.L's competition here
0L3C.L vs 0QLQ.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QLQ.L has a market cap of 5.4B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QLQ.L trades at £399.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QLQ.L's P/E ratio is 218.50. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QLQ.L's ROE of +0.13%. Regarding short-term risk, 0L3C.L is less volatile compared to 0QLQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0QLQ.L's competition here
0L3C.L vs 0ROG.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0ROG.L has a market cap of 4.3B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0ROG.L trades at £86.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0ROG.L's P/E ratio is 25.55. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0ROG.L's ROE of +0.12%. Regarding short-term risk, 0L3C.L is less volatile compared to 0ROG.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0ROG.L's competition here
0L3C.L vs 0OCD.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0OCD.L has a market cap of 4.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0OCD.L trades at £230.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0OCD.L's P/E ratio is 45.08. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0OCD.L's ROE of +0.25%. Regarding short-term risk, 0L3C.L is less volatile compared to 0OCD.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0OCD.L's competition here
0L3C.L vs 0A05.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0A05.L has a market cap of 3B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0A05.L trades at £148.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0A05.L's P/E ratio is 56.75. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0A05.L's ROE of +0.16%. Regarding short-term risk, 0L3C.L is less volatile compared to 0A05.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0A05.L's competition here
0L3C.L vs 0KGB.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0KGB.L has a market cap of 2.8B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0KGB.L trades at £31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0KGB.L's P/E ratio is 18.29. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0KGB.L's ROE of +0.14%. Regarding short-term risk, 0L3C.L is less volatile compared to 0KGB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0KGB.L's competition here
0L3C.L vs 0A23.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0A23.L has a market cap of 1.6B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0A23.L trades at £28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0A23.L's P/E ratio is -9.27. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0A23.L's ROE of -0.16%. Regarding short-term risk, 0L3C.L is less volatile compared to 0A23.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0A23.L's competition here
0L3C.L vs 0LDR.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0LDR.L has a market cap of 1.3B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0LDR.L trades at £7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0LDR.L's P/E ratio is -0.17. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0LDR.L's ROE of -0.14%. Regarding short-term risk, 0L3C.L is less volatile compared to 0LDR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0LDR.L's competition here
0L3C.L vs 0K0K.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0K0K.L has a market cap of 1.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0K0K.L trades at £33.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0K0K.L's P/E ratio is 21.09. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0K0K.L's ROE of +0.12%. Regarding short-term risk, Volatility data is not available for a full comparison. 0L3C.L has daily volatility of 0.00 and 0K0K.L has daily volatility of N/A.Check 0K0K.L's competition here
0L3C.L vs 0MT8.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0MT8.L has a market cap of 1.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0MT8.L trades at £56.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0MT8.L's P/E ratio is 8.30. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0MT8.L's ROE of +0.09%. Regarding short-term risk, 0L3C.L is less volatile compared to 0MT8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0MT8.L's competition here
0L3C.L vs 0FGL.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0FGL.L has a market cap of 1.2B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0FGL.L trades at £71.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0FGL.L's P/E ratio is 63.21. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0FGL.L's ROE of +0.12%. Regarding short-term risk, 0L3C.L is less volatile compared to 0FGL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0FGL.L's competition here
0L3C.L vs 0QV2.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QV2.L has a market cap of 1.1B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QV2.L trades at £74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QV2.L's P/E ratio is -40.50. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QV2.L's ROE of -0.08%. Regarding short-term risk, 0L3C.L and 0QV2.L have similar daily volatility (0.00).Check 0QV2.L's competition here
0L3C.L vs 0S9E.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0S9E.L has a market cap of 1B. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0S9E.L trades at £12.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0S9E.L's P/E ratio is 155.75. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0S9E.L's ROE of +0.66%. Regarding short-term risk, 0L3C.L and 0S9E.L have similar daily volatility (0.00).Check 0S9E.L's competition here
0L3C.L vs 0R9T.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R9T.L has a market cap of 723M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R9T.L trades at £48.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R9T.L's P/E ratio is 18.64. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R9T.L's ROE of +0.16%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R9T.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R9T.L's competition here
0L3C.L vs 0KFH.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0KFH.L has a market cap of 705.6M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0KFH.L trades at £26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0KFH.L's P/E ratio is 38.62. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0KFH.L's ROE of +0.18%. Regarding short-term risk, 0L3C.L and 0KFH.L have similar daily volatility (0.00).Check 0KFH.L's competition here
0L3C.L vs 0HKD.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0HKD.L has a market cap of 616.2M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0HKD.L trades at £12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0HKD.L's P/E ratio is -17.66. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0HKD.L's ROE of -0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0HKD.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0HKD.L's competition here
0L3C.L vs 0QLX.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QLX.L has a market cap of 461.7M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QLX.L trades at £1,015.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QLX.L's P/E ratio is 9.33. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QLX.L's ROE of +0.12%. Regarding short-term risk, 0L3C.L and 0QLX.L have similar daily volatility (0.00).Check 0QLX.L's competition here
0L3C.L vs 0RAR.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0RAR.L has a market cap of 328.1M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0RAR.L trades at £26.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0RAR.L's P/E ratio is 8.31. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0RAR.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0RAR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0RAR.L's competition here
0L3C.L vs 0QP7.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QP7.L has a market cap of 323.9M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QP7.L trades at £54.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QP7.L's P/E ratio is 10.21. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QP7.L's ROE of +0.20%. Regarding short-term risk, 0L3C.L and 0QP7.L have similar daily volatility (0.00).Check 0QP7.L's competition here
0L3C.L vs 0QB4.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QB4.L has a market cap of 319.3M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QB4.L trades at £12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QB4.L's P/E ratio is 27.76. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QB4.L's ROE of +0.03%. Regarding short-term risk, 0L3C.L and 0QB4.L have similar daily volatility (0.00).Check 0QB4.L's competition here
0L3C.L vs 0OR2.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0OR2.L has a market cap of 291.4M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0OR2.L trades at £28.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0OR2.L's P/E ratio is 11.62. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0OR2.L's ROE of +0.07%. Regarding short-term risk, 0L3C.L is less volatile compared to 0OR2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0OR2.L's competition here
0L3C.L vs 0ELV.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0ELV.L has a market cap of 270.3M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0ELV.L trades at £20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0ELV.L's P/E ratio is 8.31. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0ELV.L's ROE of +0.04%. Regarding short-term risk, 0L3C.L and 0ELV.L have similar daily volatility (0.00).Check 0ELV.L's competition here
0L3C.L vs 0IP1.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0IP1.L has a market cap of 216.8M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0IP1.L trades at £29.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0IP1.L's P/E ratio is 16.20. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0IP1.L's ROE of +0.02%. Regarding short-term risk, 0L3C.L is less volatile compared to 0IP1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0IP1.L's competition here
0L3C.L vs 0NES.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0NES.L has a market cap of 202.3M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0NES.L trades at £1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0NES.L's P/E ratio is 9.33. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0NES.L's ROE of -0.16%. Regarding short-term risk, 0L3C.L is less volatile compared to 0NES.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0NES.L's competition here
0L3C.L vs 0QON.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0QON.L has a market cap of 150.3M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0QON.L trades at £4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0QON.L's P/E ratio is 11.31. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0QON.L's ROE of +0.05%. Regarding short-term risk, 0L3C.L is less volatile compared to 0QON.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0QON.L's competition here
0L3C.L vs 0H8I.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0H8I.L has a market cap of 145.5M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0H8I.L trades at £1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0H8I.L's P/E ratio is -9.50. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0H8I.L's ROE of -0.10%. Regarding short-term risk, 0L3C.L is less volatile compared to 0H8I.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0H8I.L's competition here
0L3C.L vs 0DYQ.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0DYQ.L has a market cap of 144M. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0DYQ.L trades at £10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0DYQ.L's P/E ratio is 5.53. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0DYQ.L's ROE of -0.05%. Regarding short-term risk, 0L3C.L and 0DYQ.L have similar daily volatility (0.00).Check 0DYQ.L's competition here
0L3C.L vs 0R00.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0R00.L has a market cap of 0. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0R00.L trades at £60.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0R00.L's P/E ratio is 30.76. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0R00.L's ROE of +0.14%. Regarding short-term risk, 0L3C.L is less volatile compared to 0R00.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check 0R00.L's competition here
0L3C.L vs 0H7S.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, 0H7S.L has a market cap of 0. Regarding current trading prices, 0L3C.L is priced at £67.85, while 0H7S.L trades at £381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas 0H7S.L's P/E ratio is N/A. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to 0H7S.L's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. 0L3C.L has daily volatility of 0.00 and 0H7S.L has daily volatility of N/A.Check 0H7S.L's competition here
0L3C.L vs CAMB.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, CAMB.L has a market cap of 0. Regarding current trading prices, 0L3C.L is priced at £67.85, while CAMB.L trades at £82.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas CAMB.L's P/E ratio is 0.08. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to CAMB.L's ROE of +0.12%. Regarding short-term risk, 0L3C.L is less volatile compared to CAMB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check CAMB.L's competition here
0L3C.L vs PRP.L Comparison August 2025
0L3C.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0L3C.L stands at 8.3B. In comparison, PRP.L has a market cap of 0. Regarding current trading prices, 0L3C.L is priced at £67.85, while PRP.L trades at £67.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0L3C.L currently has a P/E ratio of 14.93, whereas PRP.L's P/E ratio is 0.11. In terms of profitability, 0L3C.L's ROE is +0.12%, compared to PRP.L's ROE of -0.02%. Regarding short-term risk, 0L3C.L is less volatile compared to PRP.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0L3C.L.Check PRP.L's competition here